======= DHX8 ======= == Gene Information == * **Official Symbol**: DHX8 * **Official Name**: DEAH-box helicase 8 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=1659|1659]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q14562|Q14562]] * **Interactions**: [[https://thebiogrid.org/search.php?search=DHX8&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20DHX8|Open PubMed]] * **OMIM**: [[https://omim.org/entry/600396|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: Facilitates nuclear export of spliced mRNA by releasing the RNA from the spliceosome. {ECO:0000269|PubMed:8608946}. |DEAD| |OB NTP bind| |HA2| |S1| |Helicase C| |spliceosomal complex disassembly| |ribonucleoprotein complex disassembly| |3-5 RNA helicase activity| |U2-type catalytic step 2 spliceosome| |RNA helicase activity| |catalytic step 2 spliceosome| |spliceosomal complex| |protein-containing complex disassembly| |ribonucleoprotein complex subunit organization| |nuclear body| |mRNA splicing, via spliceosome| |RNA splicing, via transesterification reactions with bulged adenosine as nucleophile| |RNA splicing, via transesterification reactions| |RNA splicing| |cellular component disassembly| |mRNA processing| |mRNA metabolic process| |RNA processing| |identical protein binding| |RNA binding| |ATP binding| |RNA metabolic process| |protein-containing complex subunit organization| |gene expression| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp513|ONC212 0.15μM R08 exp513]]|-2.75| |[[:results:exp3|Actinomycin-D 0.001μM R00 exp3]]|-2.33| |[[:results:exp485|GSK626616 14μM R08 exp485]]|-2.23| |[[:results:exp2|5-Fluorouracil 20μM R00 exp2]]|-2.21| |[[:results:exp363|GSK-J4 1-1.25μM to day4 R07 exp363]]|-2.2| |[[:results:exp538|ZLN024 50μM R08 exp538]]|-2.01| |[[:results:exp516|Pyrazinamide 100μM R08 exp516]]|-1.85| |[[:results:exp26|Oligomycin-A 20μM R00 exp26]]|-1.83| |[[:results:exp312|2-Methoxyestradiol 0.55 to 1μM on day4 R07 exp312]]|-1.81| |[[:results:exp28|Pimelic-diphenylamide-106 5μM R00 exp28]]|-1.81| |[[:results:exp478|Doxorubicin 0.02μM R08 exp478]]|-1.76| |[[:results:exp24|Nocodazole 0.2μM R00 exp24]]|-1.75| |[[:results:exp244|SB743921 0.001μM R05 exp244]]|-1.74| |[[:results:exp187|proTAME 5μM R04 exp187]]|-1.7| |[[:results:exp442|Ibrutinib 10μM R08 exp442]]|1.7| |[[:results:exp466|Cannabidiol 20μM R08 exp466]]|1.72| |[[:results:exp41|BI-2536 0.001μM R01 exp41]]|1.84| |[[:results:exp131|L-74142 5μM R03 exp131]]|1.89| |[[:results:exp512|Olaparib 4μM R08 exp512]]|1.93| |[[:results:exp449|Arsenic trioxide 60μM R08 exp449]]|1.94| |[[:results:exp506|Momordin-Ic 10μM R08 exp506]]|1.97| |[[:results:exp295|Pyronaridine 1μM R06 exp295]]|2.24| ^Gene^Correlation^ |[[:human genes:p:prim1|PRIM1]]|0.446| |[[:human genes:r:rrm1|RRM1]]|0.418| Global Fraction of Cell Lines Where Essential: 735/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|1/1| |909776.0|1/1| |bile duct|27/28| |blood|28/28| |bone|25/26| |breast|33/33| |central nervous system|56/56| |cervix|4/4| |colorectal|17/17| |esophagus|13/13| |fibroblast|1/1| |gastric|16/16| |kidney|21/21| |liver|20/20| |lung|75/75| |lymphocyte|16/16| |ovary|26/26| |pancreas|24/24| |peripheral nervous system|16/16| |plasma cell|15/15| |prostate|1/1| |skin|24/24| |soft tissue|9/9| |thyroid|2/2| |upper aerodigestive|22/22| |urinary tract|29/29| |uterus|5/5| == Essentiality in NALM6 == * **Essentiality Rank**: 992 * **Expression level (log2 read counts)**: 6.89 {{:chemogenomics:nalm6 dist.png?nolink |}}